Molecular Analysis of the Intestinal Microflora in IBD. Gerald W. Tannock

Similar documents
The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

Probiotics. What Should you. Know? Simon Stebbings University of Otago School of Medicine. University of Otago Rheumatology

Faecalibacterium prausnitzii

Materials EXCLUSION CRITERIA INCLUSION CRITERIA

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

Understanding clinical aspects of Crohn s disease and ulcerative colitis: Implications for the basic scientist

9/18/2018. The Physiological Roles of the Intestinal Microbiota. Learning Objectives

Fecal Microbiota Transplantation for Severe sepsis and Diarrhea : a Case Report

Azienda Ospedaliera S. Camillo Forlanini. Unità Operativa di Gastroenterologia. Moscow June Cosimo Prantera

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

The role of gut microbiome in IBS

The role of intestinal microbiota in metabolic disease-a novel therapeutic target.

4/16/2018. Go with your gut: the gutjoint. Learning objectives: Disclosure of Conflicts of Interest. Collaboration: OpenBiome

Microbiome GI Disorders

Research & Reviews: Journal of Microbiology and Biotechnology

Stable Isotope Probing of gut bacteria RNA. Wayne Young. Identifying gut bacteria that can use sialic acid using an RNA-SIP approach

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Intestinal Microbiota in Health and Disease

The microbiota in spondyloarthritis. Matthew Stoll MD,PhD,MSCS University of Alabama at Birmingham June 4, 2017

What GI Physicians Need to Know About Probiotics

Bovine mastitis may be associated with the deprivation of gut Lactobacillus. C. Ma, J. Zhao, X. Xi, J. Ding, H. Wang, H. Zhang and L.Y.

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

INDIVIDUAL STUDY SYNOPSIS LINPT01. EudraCT No

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence

What Have We Learned About the Microbiome in Pediatric IBD?

Nature Immunology: doi: /ni Supplementary Figure 1

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine

Issue 3, September usio

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

Supplemental Fig. 1 A. C57BL/6 (B6) C. Number of colonies in culture media B6. B6 + Abx

THE ROLE OF MICROBIOME IN IBD

Research in IBD at University of Colorado Denver

Shifts in the Intestinal Microbiota

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

A Case of Inflammatory Bowel Disease

Manipulating the gut microbiome

New and Emerging Therapies in IBD. Sarah Streett MD, AGAF Clinical Associate Professor of Medicine Stanford University

Dietary Zinc Alters the Microbiota and Decreases Resistance to Clostridium difficile Infection

Effects of probiotics in the treatment of alcoholic hepatitis: randomized controlled multicenter study

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Microbe-host interactions. Nov 15, 2006 Ch. 21 Science 307: , 2005.

Necrotizing Enterocolitis: The Role of the Immune System

Beyond the Scope: An Integrative Gastroenterologist s Approach to Digestive Disorders

Beyond the Scope: The Microbiome & The Future of Gastroenterology

The Intestinal Microbiota and the Developing Immune System

Page: 1 of 7. Fecal Analysis in the Diagnosis of Intestinal Dysbiosis

The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells.

GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH?

VITAMINS, MINERALS AND THE GUT

It Takes Guts to Grow a Brain. Josef Neu, M.D. University of Florida

Understanding probiotics and health

Gut Reaction. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures

Project context and main objectives

!Microbiology Profile, stool

Microbiome: DDW 2015 update

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis

IL-12 family members in experimental colitis. Markus F. Neurath I. Medical Clinic Johannes Gutenberg-University Mainz, Germany

5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD

Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats

The impact of the microbiome on brain and cognitive development

MOLECULAR ANALYSIS REVEALS UNIQUE MICROBIOME IN ILEAL POUCH DURING POUCHITIS COMPARED TO HEALTHY POUCHES IN ULCERATIVE

Sarkis K Mazmanian, California Institute of Technology

Analysis of the effect of probiotics on shaping human gut microbiota

Probiotics for Primary Prevention of Clostridium difficile Infection

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children

The human microbiome and how it affects heath. Nafisa M. Jadavji, PhD

Molecular mechanisms of bacteria-host interactions at the epithelial cell level

Probiotics: Implications for Pediatric Health

Study summaries L. casei 431

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

ESPEN Congress Vienna Networking with your microbiota Specific evidence-based indications. H. Lochs (Germany)

Digestive Disease Institute. Clinical Research. Discovering New Ways to Diagnose and Treat Digestive Diseases

Microbiome as Predictor of Benefit and Toxicity in Cancer Immunotherapy

Microbial Adaptations of the Microbiome. Damian R. Plichta, PhD Director of Bioinformatics

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012

Interaction between the gut and its microbiota in inflammatory bowel disease Sadaghian, Mehdi

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Fecal Microbiota Composition and Frailty

I n recent years, multiple studies have emphasised the role

Modulating the gut microbiota for better health. SP4 Klaudyna Borewicz 30/11/2017

Alexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013

Gut Microbes: Potential targets in the prevention and treatment of IBD. Neelendu Dey, MD Instructor Division of Gastroenterology

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Fructo-oligosaccharides in Crohn s disease: a prospective randomised double blind controlled trial

Reply: Gut microbiota diversity and atopic disease: Does breast-feeding play a role?

6/24/2014. How do you study microbial communities? Outnumbers Cells of the Body 10:1 Outnumber Human Genes 100:1. Michael T. Bailey, Ph.D.

Socioeconomic State & Intestinal Microbiota. Ali Keshavarzian, MD Rush University Medical Center Chicago, IL

Dr Adele Melton Gastroenterologist MBChB (Otago), FRACP

2/3/2011. Adhesion of Bifidobacterium lactis HN019 to human intestinal

New Insights on the Structure of the Human Gut Microbiota. Chaysavanh Manichanh, PhD Vall d Hebron Research Institute Barcelona

CROHN S DISEASE AND ULCERATIVE COLITIS

Dysbiosis & Inflammation

Role of the Gut Microbiota in Autoimmunity

An Emerging Trend of High Dose Probiotic Use in Clinical Practice -A Brief Survey-

Corporate Medical Policy

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

Examining the effects of pre and probiotics on gut microbiota during the ageing process

Rapid-VIDITEST. Calprotectin-Lactoferrin

Transcription:

Molecular Analysis of the Intestinal Microflora in IBD Gerald W. Tannock Department of Microbiology & Immunology, University of Otago, Dunedin, New Zealand

Commensalism

The uncultured bacterial world is greater than the cultured world. Bacterial small ribosomal subunit RNA (16S rrna) or its gene. Phylogenetic signatures contained in nucleotide base sequences. ATTCGCTTCATCGCGIAATAMTTAGCBACTEROIDESTATACTGTCCG ATTCGCTTGCAACTGIGCTAMCCATACLOSTRIDIUMCATGGTGTCCG

Phylogenetic catalogues based on 16S rrna (gene) sequences Reference to ribosomal database project II permits phylogenetic classification of sequences. Determine biodiversity. Unclassified Bacteroidetes clone frequencies detected in association with bowel biopsies from NEWLY DIAGNOSED, UNTREATED patients (CD = 20, UC = 15) and controls (14). 12.5 10.0 7.5 5.0 P <0.01 2.5 0.0 CONTROLS UC CD Clones = (63) (234) (276) GROUP Bibiloni et al., 2006, Journal of Medical Microbiology 55:1141-1149.

Fluorescence in situ hybridization (FISH)/Flow cytometry (FC) Six oligonucleotide probes that target specific sequences in 16S rrna. The probes detect phylogenetic groups of bacteria commonly present in faeces. Labeled with fluorescent dyes. FC counts the number of fluorescing cells. Bacterial groups expressed as % of total community (Eub338 probe). The six probes cover ~75% of the bowel community of healthy humans. The remaining ~25% is referred to as the phylogenetic gap.

Lay, C., et al. 2005. Applied & Environmental Microbiology 71:4153-4155. %; n = 91 European adults. Kah Weng Mah et al., 2007, Pediatric Research, in press. %; n= 17 formula-fed infants. Bifidobacteria Lab158 100 90 Atopobium group Bacteroides- Prevotella Phylogenetic gap 80 70 60 50 40 30 20 10 Clostridium cluster IV Clostridium cluster XIVa 0 0 50 100 150 200 250 300 350

Inter-subject variability = a normal range of microbiota compositions. Fecal microbiota composition determined by FISH/FACS. Ninety one healthy, European subjects. Proportions of 12 bacterial groups colorcoded.

Ileal pouch-anal anastomosis. 60 50 40 30 20 10 0 CP ANTIBIOTICS CP NO ANTIBIOTICS FAP NO ANTIBIOTICS n = 17 n = 15 www.hopkinskimmelcancercenter.org Pouchitis - can be treated with antibiotics. Total bacterial numbers the same whether CP no antibiotic, CP antibiotic, or FAP (log 10 7-8 per gram of stool). Patient group The phylogenetic gap is greater in pouchitis. This means that CP pouches contain bacteria not usually predominant in normal feces. Antibiotic treatment reduces the number of these bacteria (P <0.0001).

Community snapshots. DGGE TTGE 13 14 107 116 TI RC TC LC REC TI RC TC LC REC RC TC LC REC RC TC LC REC A 112 139 162 N In N In N In 79 80 121 124 N In N In N In N In Bibiloni et al., 2006, Journal of Medical Microbiology 55:1141-1149. B C

50 60 70 80 90 100 E37-CR Bowel biopsies reveal nationality? Albertans (Canadian) Mexican n = 36 n = 62 BACTEROIDES SPECIES 74% E44-UC E16-CR E42-CR M2-H M32-UC M39-H M16-UC M17-UC M18-UC M20-UC M19-CR M21-H E64-UC M3-H M30-H M31-H M25-H M1-UC M8-UC M34-H M36-H M37-H M40-H M22-H M27-H M38-CR M23-H M26-UC M14-UC M6-UC M35-UC M9-UC M11-H M13-H E20-CR E33-CR E29-H E56-UC E62-UC E17-H E8-CR E49-UC E9-UC E11-H E7-H E50-UC E5-H E13-CR E54-CR E25-H E26-H E23-UC E28-H E30-CR E1-CR E3-H E4-H E63-UC E2-CR E21-H E12-UC E18-CR E19-UC E22-H E31-H E34-CR E36-UC E38-H E40-H E35-H E32-H E41-CR E43-CR E6-H E61-UC E45-UC E46-CR E47-UC E55-CR E57-UC E59-UC E10-H E39-H E27-CR E51-CR E53-CR E14-CR E58-UC E15-CR E52-CR E48-UC M24-UC M28-UC M33-H M15-UC M4-UC Bibiloni et al., 2007, J. Medical Microbiology in press. M29-H

Rodents (such as IL-10 KO) with dysfunctional immune systems as models of inflammatory diseases. SPF microbiota = disease Germfree = absence of disease 3 2 1 0 Bibiloni et al., 2005. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Letters in Applied Microbiology 41 :45-51. Mouse group

WT mice IL-10-deficient mice 1 3 6 weeks after exposure to WT microbiota Bacteroides sp. 18 6 Lactobacillus Acidophilus group Eubacterium ventriosum 5 22 10 19 Clostridium cocleatum 9 Enterococcus sp. 16 Lactobacillus murinus 4 3 2 8, 12 Bifidobacterium animalis

Are the bifidobacteria involved in pathogenesis? Germfree wild type 129S6/SvEv mice and IL-10-deficient mice Monoassociated with Bifidobacterium animalis subspecies animalis ATCC 25527 Histology, colon explants (IL-12) 3.5 DUO CECUM PROX COLON TRANS COLON DIST COLON 2 Colon explants 3.0 P <0.005 2.5 1 2.0 1.5 1.0 0.5 0 WT IL-10 KO 0.0 WT KO MOUSE GROUP (n = 10-19) Mouse group Moran et al., 2006. Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in interleukin-10 knockout mice. Abstract at Digestive Diseases Week meeting.

Ankylosing spondylitis (AS) and bowel inflammation. Inflammation mainly of axial, particularly the sacroiliac, joints. Most patients are HLA-B27 positive. Between 5 and 10% of cases of AS are associated with IBD, either CD or UC. A much larger percentage of AS patients have subclinical gut inflammation manifested either by endoscopic findings or by histology. Rudwaleit & Baeten, 2006, Best Practice & Research Clinical Rheumatology 20:451-471. 1988 1998

HLA-B27 transgenic rats Rath et al.,1999, Infection & Immunity 67:2969-2974. Commensals Colitis & spondyloarthritis Germfree Absence of colitis & spondyloarthritis P <0.001

Clostridium cluster XIVa Atopobium group Bifidbacterium Clostridium cluster IV Bacteroides-Prevotella Patients, n = 15 P >0.05 Sulphate-reducing bacteria more persistent over three months in patients than controls. Klebsiella not detected. Stebbings et al., 2002,Rheumatology 41:1395-1401. Controls, n = 15

Comparison of B. vulgatus populations (DNA probe). 6 5 B. vulgatus as % total microbiota P >0.05 4 3 2 1 0 Patients Group Controls AS immune systems react differently to resident Bacteroides than controls?

AS and matched controls (21 of each) Stool sample Randomly pick 10 Bacteroides fragilis group cultures Lymphocyte proliferation 3 H-thymidine Blood sample Cytokines (IL-1β, IFN-γ, TNF-α, IL-6, IL-8, IL-17, IL-10)

AS IL10 2500 2000 IL-10 1500 1000 500 0 CAS IL10 2500 2000 IL-10 1500 1000 500 0

IL-10 production during T-cell proliferation. Bacteroides SEA 2500 3500 2000 3000 2500 1500 2000 1000 500 1500 1000 500 0 0 PATIENTS CONTROLS PATIENTS CONTROLS P <0.0001 P >0.05 AS lack anti-inflammatory activity with regard to Bacteroides?

In summary - Nucleic acid-based analytical methods have potential in discriminating between microbiota of different compositions. Experimental animal and human studies point to Bacteroides as worthy of further study in IBD and related conditions, especially where the objective is to obtain functional rather than phylogenetic knowledge.

Supertechs: Karen Munro Mary Alice Simon Corinda Taylor Postdocs: Rodrigo Bibiloni Christophe Lay Academic associates: Margaret Baird Clinical associates: Lori Baladay Chris Daynes Richard Fedorak John Highton Robin McLeod Balfour Sartor Simon Stebbings Puneeta Tandon Mark Thompson-Fawcett Bee Wah Florencia Vargas-Voracka Sponsors: Crohns and Colitis Foundation of America. Crohns and Colitis Foundation of Canada. Lottery Grants Board HealthCare Otago Charitable Trust Otago Medical Research Foundation Otago University Research Grant Otago School of Medical Sciences/Dunedin Medical School